Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices

IF 4.9 1区 医学 Q1 ONCOLOGY
{"title":"Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices","authors":"","doi":"10.1016/j.radonc.2024.110483","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>New radiotherapy machines such as Halcyon are capable of delivering dose-rate of 600 monitor-units per minute, allowing large numbers of patients treated per day. However, patient-specific quality assurance (QA) is still required, which dramatically decrease machine availability. Innovative artificial intelligence (AI) algorithms could predict QA result based on complexity metrics. However, no AI solution exists for Halcyon machines and the complexity metrics to be used have not been definitively determined. The aim of this study was to develop an AI solution capable of firstly determining the complexity indices to be obtained and secondly predicting patient-specific QA in a routine clinical setting.</p></div><div><h3>Methods</h3><p>Three hundred and eighteen beams from 56 patients with breast cancer were used. The seven complexity indices named Modulation-Complexity-Score (MCS), Small-Aperture-Score (SAS10), Beam-Area (BA), Beam-Irregularity (BI), Beam-Modulation (BM), Gantry and Collimator angles were used as input to the AI model. Machine learning (ML) and deep learning (DL) models using tensorflow were set up to predict DreamDose QA conformance.</p></div><div><h3>Results</h3><p>MCS, BI, gantry and collimator angle are not correlated with QA compliance. Therefore, ML and DL models were trained using SAS10, BA and BM complexity indices. ROC analyses enabled to find best predicted probability threshold to increase specificity and sensitivity. ML models did not show satisfactory performance with an area under-the-curve (AUC) of 0.75 and specificity and sensitivity of 0.88 and 0.86. However, optimised DL model showed better performance with an AUC of 0.95 and specificity and sensitivity of 0.98 and 0.97.</p></div><div><h3>Conclusion</h3><p>The DL model demonstrated a high degree of accuracy in its predictions of the quality assurance (QA) results. Our online predictive QA-platform offers significant time savings in terms of accelerator occupancy and working time.</p></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0167814024007539/pdfft?md5=8452ed33335a13ebc5b693ec1ada6d33&pid=1-s2.0-S0167814024007539-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814024007539","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

New radiotherapy machines such as Halcyon are capable of delivering dose-rate of 600 monitor-units per minute, allowing large numbers of patients treated per day. However, patient-specific quality assurance (QA) is still required, which dramatically decrease machine availability. Innovative artificial intelligence (AI) algorithms could predict QA result based on complexity metrics. However, no AI solution exists for Halcyon machines and the complexity metrics to be used have not been definitively determined. The aim of this study was to develop an AI solution capable of firstly determining the complexity indices to be obtained and secondly predicting patient-specific QA in a routine clinical setting.

Methods

Three hundred and eighteen beams from 56 patients with breast cancer were used. The seven complexity indices named Modulation-Complexity-Score (MCS), Small-Aperture-Score (SAS10), Beam-Area (BA), Beam-Irregularity (BI), Beam-Modulation (BM), Gantry and Collimator angles were used as input to the AI model. Machine learning (ML) and deep learning (DL) models using tensorflow were set up to predict DreamDose QA conformance.

Results

MCS, BI, gantry and collimator angle are not correlated with QA compliance. Therefore, ML and DL models were trained using SAS10, BA and BM complexity indices. ROC analyses enabled to find best predicted probability threshold to increase specificity and sensitivity. ML models did not show satisfactory performance with an area under-the-curve (AUC) of 0.75 and specificity and sensitivity of 0.88 and 0.86. However, optimised DL model showed better performance with an AUC of 0.95 and specificity and sensitivity of 0.98 and 0.97.

Conclusion

The DL model demonstrated a high degree of accuracy in its predictions of the quality assurance (QA) results. Our online predictive QA-platform offers significant time savings in terms of accelerator occupancy and working time.

使用 Halcyon 特定复杂性指数对乳腺 IMRT 放射治疗计划中患者特定质量保证进行机器学习和深度学习预测。
简介Halcyon 等新型放射治疗机能够提供每分钟 600 个监测单位的剂量率,每天可治疗大量患者。然而,仍需要针对患者的质量保证(QA),这大大降低了机器的可用性。创新的人工智能(AI)算法可以根据复杂性指标预测质量保证结果。然而,目前还没有适用于 Halcyon 机器的人工智能解决方案,所使用的复杂度指标也尚未明确确定。本研究的目的是开发一种人工智能解决方案,首先能确定要获得的复杂度指标,其次能在常规临床环境中预测特定患者的 QA:方法:使用了 56 名乳腺癌患者的 318 个横梁。方法:使用了 56 名乳腺癌患者的 318 个光束,将调制-复杂度-分数(MCS)、小孔径-分数(SAS10)、光束-面积(BA)、光束-不规则性(BI)、光束-调制(BM)、龙门架和准直器角度等七个复杂度指数作为人工智能模型的输入。使用 tensorflow 建立了机器学习(ML)和深度学习(DL)模型,以预测 DreamDose QA 的一致性:结果:MCS、BI、龙门架和准直器角度与 QA 合规性无关。因此,使用 SAS10、BA 和 BM 复杂性指数对 ML 和 DL 模型进行了训练。通过 ROC 分析,找到了提高特异性和灵敏度的最佳预测概率阈值。ML 模型的曲线下面积(AUC)为 0.75,特异性和灵敏度分别为 0.88 和 0.86,表现并不令人满意。然而,优化的 DL 模型显示出更好的性能,其 AUC 为 0.95,特异性和灵敏度分别为 0.98 和 0.97:DL模型对质量保证(QA)结果的预测具有很高的准确性。我们的在线预测质量保证平台大大节省了加速器占用和工作时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiotherapy and Oncology
Radiotherapy and Oncology 医学-核医学
CiteScore
10.30
自引率
10.50%
发文量
2445
审稿时长
45 days
期刊介绍: Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信